Exploring recent advances in signaling pathways and hallmarks of uveal melanoma: a comprehensive review.

Q3 Medicine
Exploration of targeted anti-tumor therapy Pub Date : 2025-04-02 eCollection Date: 2025-01-01 DOI:10.37349/etat.2025.1002306
Majid Banimohammad, Parsa Khalafi, Danial Gholamin, Zahra Bangaleh, Nahid Akhtar, Abhishikt David Solomon, Pranav Kumar Prabhakar, Samira Sanami, Ajit Prakash, Hamidreza Pazoki-Toroudi
{"title":"Exploring recent advances in signaling pathways and hallmarks of uveal melanoma: a comprehensive review.","authors":"Majid Banimohammad, Parsa Khalafi, Danial Gholamin, Zahra Bangaleh, Nahid Akhtar, Abhishikt David Solomon, Pranav Kumar Prabhakar, Samira Sanami, Ajit Prakash, Hamidreza Pazoki-Toroudi","doi":"10.37349/etat.2025.1002306","DOIUrl":null,"url":null,"abstract":"<p><p>The purpose of this review was to provide a comprehensive review of the latest insights on the pathogenesis of uveal melanoma (UM) and its intracellular pathways. This article covers the epidemiology of UM, racial predispositions, cytogenetic and chromosomal alterations, gene mutations, key defective pathways, and their underlying mechanisms, as well as the application of hallmarks of cancer to UM. A key knowledge gap remains in identifying the most effective targeted therapy and determining the central pathway linking multiple signaling networks. UM is a malignant tumor arising from uveal melanocytes, predominantly affecting the choroid, with both genetic and epigenetic contributors. Key cytogenetic alterations include monosomy 3, chromosome 6p gain, chromosome 1p loss, and chromosome 8q gain. The most important UM-related signaling pathways are RAS/MAPK, PI3K/Akt/mTOR, Hippo-YAP, retinoblastoma (Rb), and p53 pathways. In the RAS/MAPK pathway, <i>GNAQ</i>/<i>GNA11</i> mutations occur which account for more than 80% of UM cases. The PI3K/Akt/mTOR pathway promotes cyclin D1 overexpression and MDM2 upregulation, leading to p53 pathway inhibition. <i>GNAQ</i>/<i>GNA11</i> mutations activate YAP via the Trio-RhoGTPase/RhoA/Rac1 signaling circuit in the Hippo-YAP pathway. Rb pathway dysregulation results from cyclin D1 overexpression or cyclin-dependent kinase inhibitor (CDKI) inactivation. In the p53 pathway, UM is characterized by <i>p53</i> mutations, MDM2 overexpression, and Bcl-2 deregulation. Eventually, the ARF-MDM2 axis serves as a critical link between the RAS and p53 pathways. Hallmarks of cancer, such as evasion of growth suppression and self-sufficiency in growth signals, are also evident in UM. Genetic and epigenetic alterations, including <i>NSB1</i>, <i>MDM2</i> and <i>CCND1</i> amplification, and <i>BAP1</i> mutations, play pivotal roles in UM pathobiology. Thus, UM exhibits a multifactorial pathology. By consolidating key mechanisms underlying UM pathogenesis, this review provides a comprehensive perspective on the involved pathways, offering insights that may facilitate the development of effective therapeutic strategies.</p>","PeriodicalId":73002,"journal":{"name":"Exploration of targeted anti-tumor therapy","volume":"6 ","pages":"1002306"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11964777/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Exploration of targeted anti-tumor therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37349/etat.2025.1002306","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The purpose of this review was to provide a comprehensive review of the latest insights on the pathogenesis of uveal melanoma (UM) and its intracellular pathways. This article covers the epidemiology of UM, racial predispositions, cytogenetic and chromosomal alterations, gene mutations, key defective pathways, and their underlying mechanisms, as well as the application of hallmarks of cancer to UM. A key knowledge gap remains in identifying the most effective targeted therapy and determining the central pathway linking multiple signaling networks. UM is a malignant tumor arising from uveal melanocytes, predominantly affecting the choroid, with both genetic and epigenetic contributors. Key cytogenetic alterations include monosomy 3, chromosome 6p gain, chromosome 1p loss, and chromosome 8q gain. The most important UM-related signaling pathways are RAS/MAPK, PI3K/Akt/mTOR, Hippo-YAP, retinoblastoma (Rb), and p53 pathways. In the RAS/MAPK pathway, GNAQ/GNA11 mutations occur which account for more than 80% of UM cases. The PI3K/Akt/mTOR pathway promotes cyclin D1 overexpression and MDM2 upregulation, leading to p53 pathway inhibition. GNAQ/GNA11 mutations activate YAP via the Trio-RhoGTPase/RhoA/Rac1 signaling circuit in the Hippo-YAP pathway. Rb pathway dysregulation results from cyclin D1 overexpression or cyclin-dependent kinase inhibitor (CDKI) inactivation. In the p53 pathway, UM is characterized by p53 mutations, MDM2 overexpression, and Bcl-2 deregulation. Eventually, the ARF-MDM2 axis serves as a critical link between the RAS and p53 pathways. Hallmarks of cancer, such as evasion of growth suppression and self-sufficiency in growth signals, are also evident in UM. Genetic and epigenetic alterations, including NSB1, MDM2 and CCND1 amplification, and BAP1 mutations, play pivotal roles in UM pathobiology. Thus, UM exhibits a multifactorial pathology. By consolidating key mechanisms underlying UM pathogenesis, this review provides a comprehensive perspective on the involved pathways, offering insights that may facilitate the development of effective therapeutic strategies.

探索葡萄膜黑色素瘤信号通路和特征的最新进展:全面回顾。
本文综述了葡萄膜黑色素瘤(uveal melanoma, UM)的发病机制及其细胞内通路的最新进展。本文涵盖了UM的流行病学,种族倾向,细胞遗传学和染色体改变,基因突变,关键缺陷途径及其潜在机制,以及癌症特征在UM中的应用。在确定最有效的靶向治疗和确定连接多个信号网络的中心途径方面,一个关键的知识缺口仍然存在。UM是一种由葡萄膜黑色素细胞引起的恶性肿瘤,主要影响脉络膜,有遗传和表观遗传因素。关键的细胞遗传学改变包括单体3、染色体6p增益、染色体1p丢失和染色体8q增益。最重要的um相关信号通路是RAS/MAPK、PI3K/Akt/mTOR、hippop - yap、视网膜母细胞瘤(Rb)和p53通路。在RAS/MAPK通路中,发生GNAQ/GNA11突变,占UM病例的80%以上。PI3K/Akt/mTOR通路促进cyclin D1过表达和MDM2上调,导致p53通路抑制。GNAQ/GNA11突变通过Hippo-YAP通路中的Trio-RhoGTPase/RhoA/Rac1信号通路激活YAP。Rb通路失调是由细胞周期蛋白D1过表达或细胞周期蛋白依赖性激酶抑制剂(CDKI)失活引起的。在p53通路中,UM以p53突变、MDM2过表达和Bcl-2失调为特征。最终,ARF-MDM2轴作为RAS和p53通路之间的关键纽带。癌症的特征,如逃避生长抑制和生长信号的自给自足,在UM中也很明显。遗传和表观遗传改变,包括NSB1、MDM2和CCND1扩增以及BAP1突变,在UM病理生物学中起关键作用。因此,UM表现出多因素病理。通过巩固UM发病机制的关键机制,本综述提供了对相关途径的全面视角,提供了可能有助于开发有效治疗策略的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.80
自引率
0.00%
发文量
0
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信